Germ cell tumor historical perspective: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) Created page with "* Polyebryoma was first described in 1936 by the French investigator Felix Albert Peyron who had a remarkable interest in polyembryoma neoplasm. He started his research paper..." |
Hudakarman (talk | contribs) No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
* Polyebryoma was first described in 1936 by the French investigator Felix Albert Peyron who had a remarkable interest in polyembryoma neoplasm. He started his research paper in 1919 and wrote his last paper in 1941. His first work involves testicular polyembryoma. It can also be seen in the ovary. | * Polyebryoma was first described in 1936 by the French investigator Felix Albert Peyron who had a remarkable interest in polyembryoma neoplasm. He started his research paper in 1919 and wrote his last paper in 1941. His first work involves testicular polyembryoma. It can also be seen in the ovary <ref name="pmid26840034">{{cite journal| author=Young RH, Stall JN, Sevestre H| title=The Polyembryoma: One of the Most Intriguing Human Neoplasms, With Comments on the Investigator Who Brought it to Light, Albert Peyron. | journal=Int J Gynecol Pathol | year= 2016 | volume= 35 | issue= 2 | pages= 93-105 | pmid=26840034 | doi=10.1097/PGP.0000000000000282 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26840034 }} </ref> | ||
*In 2007, Looijenga and colleagues reviewed studies of GCT risk in various DSD diagnoses known at that time, and developed risk categories based on the consensus nomenclature, which have been incrementally refined since that time <ref name="pmid17875493">{{cite journal| author=Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP| title=Tumor risk in disorders of sex development (DSD). | journal=Best Pract Res Clin Endocrinol Metab | year= 2007 | volume= 21 | issue= 3 | pages= 480-95 | pmid=17875493 | doi=10.1016/j.beem.2007.05.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17875493 }} </ref> | |||
==References== | |||
{{reflist}} | |||
Latest revision as of 19:34, 16 August 2019
- Polyebryoma was first described in 1936 by the French investigator Felix Albert Peyron who had a remarkable interest in polyembryoma neoplasm. He started his research paper in 1919 and wrote his last paper in 1941. His first work involves testicular polyembryoma. It can also be seen in the ovary [1]
- In 2007, Looijenga and colleagues reviewed studies of GCT risk in various DSD diagnoses known at that time, and developed risk categories based on the consensus nomenclature, which have been incrementally refined since that time [2]
References
- ↑ Young RH, Stall JN, Sevestre H (2016). "The Polyembryoma: One of the Most Intriguing Human Neoplasms, With Comments on the Investigator Who Brought it to Light, Albert Peyron". Int J Gynecol Pathol. 35 (2): 93–105. doi:10.1097/PGP.0000000000000282. PMID 26840034.
- ↑ Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP (2007). "Tumor risk in disorders of sex development (DSD)". Best Pract Res Clin Endocrinol Metab. 21 (3): 480–95. doi:10.1016/j.beem.2007.05.001. PMID 17875493.